Brief: Cleveland Biolabs Reports Quarterly Loss Per Share Of $0.11
15/05/2018 13:13
May 15 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS INC - REVENUE FOR Q1 OF 2018 DECREASED
TO $0.2
MILLION COMPARED TO $0.6 MILLION FOR Q1 OF 2017
* CLEVELAND BIOLABS INC QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc